九九云7天试用-快连加速器app

九九云7天试用-快连加速器app

Male Apellis employee holding a horse saddle

Luis
Supply Chain at Apellis

九九云7天试用-快连加速器app

Learn More
Folded page of a newspaper

九九云7天试用-快连加速器app

九九云7天试用-快连加速器app

Apellis Pharmaceuticals Reports Second Quarter 2024 Financial Results

九九云7天试用-快连加速器app

Apellis Completes Enrollment in Two Phase 3 Studies of the Targeted C3 Therapy, Pegcetacoplan, in Patients with Geographic Atrophy (GA)

w加速器官网

Apellis Completes Enrollment in Phase 3 Study of Pegcetacoplan in Treatment-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Newsroom
w加速器安卓

@ApellisPharma

A man with a baby in a baby carrier

九九云7天试用-快连加速器app

FOR PATIENTS
Erlenmeyer flask, which represents the pre-clinical and clinical studies sponsored by Apellis Pharmaceuticals

九九云7天试用-快连加速器app

for paroxysmal nocturnal hemoglobinuria, geographic atrophy,
C3 glomerulopathy, and cold agglutinin disease.

PIPELINE
3 arrows of different lengths, which represents the development status of pre-clinical and clinical studies for C3 complement targeted therapies

九九云7天试用-快连加速器app

are targeted C3 therapies. These include potential medicines for a broad range of serious diseases driven by uncontrolled or excessive activation of the complement system.

CLINICAL TRIALS

九九云7天试用-快连加速器app

so that Alexander, who is living with C3 glomerulopathy, can take his pug for a hike

We challenge conventional thinking and always question if there's a better way.

Join Us
w加速器app

Patricia
Quality Assurance at Apellis

快连APV  vpn网页加速器  tai letsVPN  极光，加速器  【加速器】 VPN  黑洞加速噐安卓版